Beyond Type 1's editorial staff reflects on the highlights, lowlights, insights, and biggest takeaways from the biggest diabetes conference of the year.

Today we know that there is no single approach or nutritional treatment for people with diabetes (any type) or prediabetes

The American Diabetes Association included in its guidelines and overall consensus of 2019, a review and update of intrahospital management of diabetes

The DiabetesMine™ D-Data ExChange is a biannual event where diabetes advocates, pharma leaders, developers, clinicians, designers, and other groups interested in diabetes tech for diabetes management, and of course a better quality of life, get together.

Tidepool announced that they have partnered with Medtronic to create an interoperable automated insulin pump system.

The immunotherapy drug teplizumab was shown to delay Type 1 diabetes diagnosis a median of 2 years in children and adults at high risk.

Participants using Control-IQ saw an increased time in range, lowered HbA1c, and less time in hyperglycemia and hypoglycemia.

The Parker Institute, JDRF and The Leona M. and Harry B. Helmsley Charitable Trust announced a research initiative to study immunotherapy-induced diabetes.

Two studies presented by ADA + JDRF found that access to continuous glucose monitoring in children with diabetes improves glycemic control • Insulet announced positive trial results regarding the Omnipod® HorizonTM Hybrid Closed-Loop System • Study results were presented from Tandem’s Control-IQ hybrid closed loop using the t:slim X2 insulin pump with the Dexcom G6 continuous glucose monitor

On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.

Beyond Type 1 recently spoke with Eric Paslay about life with diabetes, the importance of role models, and what he hopes to accomplish with his new podcast.

Several members of Type One Run share their take on mental health and the connection between exercise, T1D management, and a healthy outlook on life.

Beyond Type 1 recently talked to actress Jennifer Bartels about her diagnosis, how she is bringing awareness to T1D, and her plans for the future.

Just like with any new insulin pump or medication, it takes time to adapt to using Loop. It is important to understand the differences from typical pumping.

Alexi Melvin discusses the competitive nature of social media and the way it affects the T1D community in particular.